Latest News & Updates

Breaking News

  • 1 day ago

  • Vaibhavi M.

Jupiter Neurosciences Appoints Dr. Tomas J. Philipson as Board Director with FDA and Health Economics Background
Breaking News
Onconetix Acquisition Target Realbotix Secures UK Pilot Deal with Bloom for Humanoid Care Robots

Vaibhavi M.

Other trending news you may like to read

Jupiter Neurosciences Appoints Dr. Tomas J. Philipson as Board Director with FDA and Health Economics Background

Jupiter Neurosciences adds former White House Council of Economic Advisers Acting Chairman Dr. Tomas Philipson to its board, effective June 26, 2026.

Vaibhavi M.

Pharma Now

Onconetix Acquisition Target Realbotix Secures UK Pilot Deal with Bloom for Humanoid Care Robots

Realbotix, Onconetix's pending acquisition target, launches a UK humanoid robot pilot with Bloom Procurement Services for elderly care settings.

Vaibhavi M.

Pharma Now

Celea Therapeutics Secures $180 Million to Launch SURPASS-IPF Phase 3 Trial Against Standard of Care

Celea Therapeutics raises $180M to launch SURPASS-IPF, the first head-to-head Phase 3 trial in idiopathic pulmonary fibrosis, targeting Q3 2026.

Vaibhavi M.

Pharma Now

EMA Initiates Phased Review of Revolution Medicines' Daraxonrasib for Metastatic Pancreatic Cancer

EMA's CHMP opens phased review of Revolution Medicines' daraxonrasib, setting a procedural template for sequenced dossier submissions under reformed EU legislation.

Vaibhavi M.

Pharma Now